LXRX loaded pre market at $17.47 on this news we hit $23.00 premarket!
Lexicon Pharma shares rally 48% premarket on positive trial of diabetes treatment
7:39 AM ET 9/9/16 | MarketWatch
Shares of Lexicon Pharmaceuticals Inc. (LXRX) rallied a stunning 48% in premarket trade Friday, after the company reported positive results from a late-stage trial of a treatment for type 1 diabetes. The company said the Phase 3 trial of sotagliflozin met its primary endpoint, showing a statistically significant improvement in blood sugar control in patients with type 1 diabetes on a background of optimized insulin. The improvement was made without an increase in severe hypoglycemia, a serious health challenge in type 1 diabetes. Lexicon is working with Sanofi to develop the compound for use in type 1 and type 2 diabetes. Shares were up 15% in the year through Thursday's close, while the S&P 500 has gained 7%.
-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com
> Dow Jones Newswires
September 09, 2016 07:39 ET (11:39 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
